🇺🇸 FDA

Intelligence · Clinical Pipeline

Chinese Academy of Pipeline

All ClinicalTrials.gov programs at Chinese Academy of — phase, modality, and trial IDs.

Programs
432

Quick answer

Chinese Academy of has 432 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. dapagliflozin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Kidney Injury

    phase 2 small molecule active

    1 trial

  2. deferoxamine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Intracerebral Hemorrhage

    phase 2 small molecule active

    1 trial

  3. docetaxel, cisplatin, fluorouracil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Locally Advanced Head and Neck Carcinoma

    phase 2 small molecule completed

    1 trial

  4. docetaxol, cisplatin, capecitabine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Advanced Breast Cancer

    phase 2 small molecule active

    1 trial

  5. donepezil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cognitive Impairment

    phase 2 small molecule active

    1 trial

  6. electroacupuncture group

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Urinary Stress Incontinence

    phase 2 other completed

    1 trial

  7. escitalopram

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Addiction

    phase 2 small molecule terminated

    1 trial

  8. gemcitabine and cisplatin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Squamous Cell Carcinoma

    phase 2 small molecule completed

    1 trial

  9. infloran

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Enterocolitis, Necrotizing

    phase 2 other terminated

    1 trial

  10. iv ibuprofen

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Extremely Premature Infants

    phase 2 small molecule active

    1 trial

  11. leucovorin+5-FU

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colonic Diseases

    phase 2 small molecule active

    1 trial

  12. leucovorin, oxaliplatin, docetaxel, S-1

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Gastric Cancer

    phase 2 small molecule active

    1 trial

  13. levamisole

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Anemia

    phase 2 small molecule active

    1 trial

  14. low-dose Recombinant SARS-CoV-2 Vaccine (CHO cell)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19

    phase 2 mab completed

    1 trial

  15. mesenchymal stem cell

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Kidney Transplant

    phase 2 mab active

    1 trial

  16. mesenchymal stem cell

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lupus Nephritis

    phase 2 mab active

    1 trial

  17. middle-dose Norovirus Bivalent (GI.1 / GII.4) Vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Norovirus Infections

    phase 2 mab active

    1 trial

  18. nab-paclitaxel

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Breast Cancer

    phase 2 small molecule active

    1 trial

  19. nal-IRI /Experimental

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Metastatic Gastric Adenocarcinoma

    phase 2 small molecule active

    1 trial

  20. nanoliposomal irinotecan

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Head & Neck Cancer

    phase 2 small molecule completed

    1 trial

  21. nasogastric tube decompression

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pancreaticoduodenectomy

    phase 2 other active

    1 trial

  22. nedaplatin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Central Nervous System Tumors

    phase 2 small molecule active

    1 trial

  23. nerve growth factor

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Traumatic Brain Injury

    phase 2 small molecule completed

    1 trial

  24. nicotinamide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cutaneous Lupus Erythematosus

    phase 2 small molecule active

    1 trial

  25. nicotinamide adenine dinucleotid/nicotinamide mononucleotide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Immune Thrombocytopenia

    phase 2 small molecule active

    1 trial

  26. nivolumab, ipilimumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma (HCC)

    phase 2 small molecule completed

    1 trial

  27. open discectomy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lumbar Disc Herniation

    phase 2 other active

    1 trial

  28. oxaliplatin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Stomach Neoplasms

    phase 2 small molecule active

    1 trial

  29. pectin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Crohn's Disease

    phase 2 small molecule terminated

    1 trial

  30. pemetrexed

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Brain Metastases

    phase 2 small molecule active

    1 trial

  31. rabbit ATG, Cyclosporine, Levamisole

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Aplastic Anemia

    phase 2 small molecule completed

    1 trial

  32. recombinant human erythropoietin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hypoxic-Ischemic Encephalopathy

    phase 2 small molecule completed

    1 trial

  33. recombinant human erythropoietin (rhEpo)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Infant, Premature

    phase 2 small molecule active

    1 trial

  34. rhGM-CSF

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pulmonary Alveolar Proteinosis

    phase 2 small molecule active

    1 trial

  35. sarcosine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Schizophrenia

    phase 2 small molecule completed

    1 trial

  36. self-expandable 125I radioactive seeds-loaded-stent

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cholangiocellular Carcinoma

    phase 2 other completed

    1 trial

  37. sintilimab+IBI310+chemotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    NSCLC Stage II

    phase 2 small molecule active

    1 trial

  38. sintiliman plus LDRT

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Gastric Cancer

    phase 2 small molecule active

    1 trial

  39. split-virion pandemic influenza vaccine (H5N1 strain NIBRG-14)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Influenza

    phase 2 mab completed

    2 trials

  40. standard triple region

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Helicobacter Pylori Infection

    phase 2 small molecule completed

    1 trial

  41. the standard "3+7" regimen

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Newly Diagnosed Acute Myeloid Leukemia (AML)

    phase 2 small molecule active

    1 trial

  42. tislelizumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Stage III

    phase 2 small molecule active

    1 trial

  43. tislelizumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Gastric

    phase 2 small molecule active

    1 trial

  44. umbilical cord mesenchymal stem cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Peripheral Arterial Disease

    phase 2 mab completed

    1 trial

  45. umbilical cord mesenchymal stem cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cartilage Damage

    phase 2 mab active

    1 trial

  46. vitamin C

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Carcinoma, Non-Small-Cell Lung

    phase 2 small molecule completed

    1 trial

  47. zanubrutinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Antiphospholipid Syndrome

    phase 2 small molecule active

    1 trial

  48. zoledronic acid

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Congenital Dyserythropoietic Anemia (CDA)

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many pipeline programs does Chinese Academy of have?

432 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.